Skip to main content
FMS logo
FMS
(NYSE)
Fresenius Medical Care AG
$22.41-- (--)
Loading... - Market loading

Fresenius Medical Care (FMS) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Fresenius Medical Care AG
FMSNYSEHealthcareMedical Care Facilities

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, ambulant treatment, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Company Information

CEOHelen Giza
Founded1996
IPO DateSeptember 19, 1996
Employees111,513
CountryGermany
Fiscal YearJanuary - December

Stock Details

ExchangeNYSE (NYSE)
CurrencyEUR - EUR
TypeStock

Corporate Identifiers

CIK0001333141
CUSIP358029106
ISINUS3580291066
SIC8090

Leadership Team & Key Executives

Joseph E. Turk Jr.
Chief Executive Officer of Care Enablement and Member of Management Board
Craig Cordola FACHE, M.B.A., M.H.A.
Chief Executive Officer of Care Delivery and Member of Management Board
Helen Giza
Chair of Management Board and Chief Executive Officer
Martin Fischer
Chief Financial Officer and Member of the Management Board
Jorg Haring
Member of the Management Board, Global Head of Legal,Compliance and Human Resources and Labor Director
Roberto Fuste
Executive Advisor for Regional Strategy
Charles Hugh-Jones M.D.
Global Chief Medical Officer and Member of Management Board
Dr. Dominik Heger
Executive Vice President and Head of Investor Relations, Strategic Development and Communications
Joachim Weith
Senior Vice President of Corporate Communications and Governmental Affairs
Dr. Gail-Suzanne Brown
Senior Vice President of Research and Development